Modulation of memory by insulin and glucose: Neuropsychological observations in Alzheimer's disease

European Journal of Pharmacology

Volumn 490, Issue 1-3, 2004, Pages 97-113

  Watson, G Stennis ^b   Craft, Suzanne ^a  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b NONE

Author keywords

Alzheimer's disease; Glucose; Insulin; Memory

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN E; GLUCOSE; INSULIN; MUSCIMOL; OTENZEPAD;

ACUTE DRUG ADMINISTRATION; ALLELE; ALZHEIMER DISEASE; BRAIN NERVE CELL; BRAIN REGION; CHOLINERGIC ACTIVITY; CHRONIC DISEASE; CLINICAL OBSERVATION; COGNITIVE DEFECT; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GENETIC ANALYSIS; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MEMORY; MEMORY DISORDER; MENTAL FUNCTION; MOLECULAR MECHANICS; NERVOUS SYSTEM DEVELOPMENT; NEUROPSYCHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SENESCENCE; SEX DIFFERENCE;

EID: 1842734649     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.02.048     Document Type: Article

References (135)

1. Allen J.B., Gross A.M., Aloia M.S., Billingsley C. The effects of glucose on nonmemory cognitive functioning in the elderly. Neuropsychologia. 34:1996;459-465.
2. Apelt J., Mehlhorn G., Schliebs R. Insulin-sensitive GLUT4 glucose transporters are colocalized with GLUT3-expressing cells and demonstrate a chemically distinct neuron-specific localization in rat brain. J. Neurosci. Res. 57:1999;693-705.
3. Austin E.J., Deary I.J. Effects of repeated hypoglycemia on cognitive function: a psychometrically validated reanalysis of the Diabetes Control and Complications Trial data. Diabetes Care. 22:1999;1273-1277.
4. Authier F., Posner B.I., Bergeron J.J. Insulin-degrading enzyme. Clin. Invest. Med. 19:1996;149-160.
5. Backman L., Small B.J., Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 124:2001;96-102.
6. Badr G.A., Tang J., Ismail-Beigi F., Kern T.S. Diabetes downregulates GLUT1 expression in the retina and its microvessels but not in the cerebral cortex or its microvessels. Diabetes. 49:2000;1016-1021.
7. Banks W.A., Jaspan J.B., Huang W., Kastin A.J. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides. 18:1997;1423-1429.
8. Baskin D.G., Figlewicz D.P., Woods S.C., Porte D. Jr., Dorsa D.M. Insulin in the brain. Annu. Rev. Physiol. 49:1987;335-347.
9. Baura G.D., Foster D.M., Porte D. Jr., Kahn S.E., Bergman R.N., Cobelli C., Schwartz M.W. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92:1993;1824-1830.
10. Benton D., Owens D.S. Blood glucose and human memory. Psychopharmacology (Berl.). 113:1993;83-88.
11. Benton D., Owens D.S., Parker P.Y. Blood glucose influences memory and attention in young adults. Neuropsychologia. 32:1994;595-607.
12. Bernstein H.G., Schwarzberg H., Reiser M., Gunther O., Dorn A. Intracerebroventricular infusion of insulin alters the behavior of rats not related to food intake. Endocrinol. Exp. 20:1986;387-392.
13. Blanchard J.G., Duncan P.M. Effect of combinations of insulin, glucose and scopolamine on radial arm maze performance. Pharmacol. Biochem. Behav. 58:1997;209-214.
14. Born J., Lange T., Kern W., McGregor G.P., Bickel U., Fehm H.L. Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. 5:2002;514-516.
15. Brant A.M., Jess T.J., Milligan G., Brown C.M., Gould G.W. Immunological analysis of glucose transporters expressed in different regions of the rat brain and central nervous system. Biochem. Biophys. Res. Commun. 192:1993;1297-1302.
16. Bruning J.C., Gautam D., Burks D.J., Gillette J., Schubert M., Orban P.C., Klein R., Krone W., Muller-Wieland D., Kahn C.R. Role of brain insulin receptor in control of body weight and reproduction. Science. 289:2000;2122-2125.
17. Byrne J.H. Learning and memory: basic mechanisms. Squire L.R., Bloom F.E., McConnell S.K., Roberts J.L., Spitzer N.C., Zigmond M.J. Fundamental Neuroscience. 2003;1276-1298 Academic Press, San Diego, CA.
18. Chen Z., Ljunggren H.G., Bogdanovic N., Nennesmo I., Winblad B., Zhu J. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice. Brain Res. 931:2002;135-145.
19. Clayson S.J. Effect of hypoglycemia on T-maze learning in rats. Phys. Ther. 51:1971;991-999.
20. Cook D.G., Leverenz J.B., McMillan P.J., Kulstad J.J., Ericksen S., Roth R.A., Schellenberg G.D., Jin L.W., Kovacina K.S., Craft S. Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele. Am. J. Pathol. 162:2003;313-319.
21. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
22. Cornford E.M., Hyman S., Cornford M.E., Clare-Salzler M. Down-regulation of blood-brain glucose transport in the hyperglycemic nonobese diabetic mouse. Neurochem. Res. 20:1995;869-873.
23. Craft S., Zallen G., Baker L.D. Glucose and memory in mild senile dementia of the Alzheimer type. J. Clin. Exp. Neuropsychol. 14:1992;253-267.
24. Craft S., Dagogo-Jack S.E., Wiethop B.V., Murphy C., Nevins R.T., Fleischman S., Rice V., Newcomer J.W., Cryer P.E. Effects of hyperglycemia on memory and hormone levels in dementia of the Alzheimer type: a longitudinal study. Behav. Neurosci. 107:1993;926-940.
25. Craft S., Murphy C., Wemstrom J. Glucose effects on complex memory and nonmemory tasks - the influence of age, sex, and glucoregulatory response. Psychobiology. 22:1994;95-105.
26. Craft S., Newcomer J., Kanne S., Dagogo-Jack S., Cryer P., Sheline Y., Luby J., Dagogo-Jack A., Alderson A. Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol. Aging. 17:1996;123-130.
27. Craft S., Peskind E., Schwartz M.W., Schellenberg G.D., Raskind M., Porte D. Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 50:1998;164-168.
28. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., Cherrier M., Lofgreen C., Latendresse S., Petrova A., Plymate S., Raskind M., Grimwood K., Veith R.C. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch. Gen. Psychiatry. 56:1999;1135-1140.
29. Craft S., Asthana S., Schellenberg G., Cherrier M., Baker L.D., Newcomer J., Plymate S., Latendresse S., Petrova A., Raskind M., Peskind E., Lofgreen C., Grimwood K. Insulin metabolism in Alzheimer's disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology. 70:1999;146-152.
30. Craft S., Asthana S., Schellenberg G., Baker L., Cherrier M., Boyt A.A., Martins R.N., Raskind M., Peskind E., Plymate S. Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype. Ann. N.Y. Acad. Sci. 903:2000;222-228.
31. Craft S., Asthana S., Cook D.G., Baker L.D., Cherrier M., Purganon K., Wait C., Petrova A., Latendresse S., Watson G.S., Newcomer J.W., Schellenberg G.D., Krohn A.J. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology. 28:2003;809-822.
32. Degroot A., Kornecook T., Quirion R., DeBow S., Parent M.B. Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Res. 979:2003;71-77.
33. Desgranges B., Baron J.C., Lalevee C., Giffard B., Viader F., de La Sayette V., Eustache F. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain. 125:2002;1116-1124.
34. Di Luca M., Ruts L., Gardoni F., Cattabeni F., Biessels G.J., Gispen W.H. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetologia. 42:1999;693-701.
35. El Messari S., Leloup C., Quignon M., Brisorgueil M.J., Penicaud L., Arluison M. Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J. Comp. Neurol. 399:1998;492-512.
36. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., Alborn A.M., Nordborg C., Peterson D.A., Gage F.H. Neurogenesis in the adult human hippocampus. Nat. Med. 4:1998;1313-1317.
37. Fanelli C.G., Paramore D.S., Hershey T., Terkamp C., Ovalle F., Craft S., Cryer P.E. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes. Diabetes. 47:1998;1920-1927.
38. Flint R.W. Jr., Riccio D.C. Pretest administration of glucose attenuates infantile amnesia for passive avoidance conditioning in rats. Dev. Psychobiol. 31:1997;207-216.
39. Foster J.K., Lidder P.G., Sunram S.I. Glucose and memory: fractionation of enhancement effects? Psychopharmacology (Berl.). 137:1998;259-270.
40. Frenkel D., Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc. Natl. Acad. Sci. U. S. A. 99:2002;5675-5679.
41. Frick K.M., Burlingame L.A., Delaney S.S., Berger-Sweeney J. Sex differences in neurochemical markers that correlate with behavior in aging mice. Neurobiol. Aging. 23:2002;145-158.
42. Frolich L., Blum-Degen D., Riederer P., Hoyer S. A disturbance in the neuronal insulin receptor signal transduction in sporadic Alzheimer's disease. Ann. N.Y. Acad. Sci. 893:1999;290-293.
43. Garrido G.E., Furuie S.S., Buchpiguel C.A., Bottino C.M., Almeida O.P., Cid C.G., Camargo C.H., Castro C.C., Glabus M.F., Busatto G.F. Relation between medial temporal atrophy and functional brain activity during memory processing in Alzheimer's disease: a combined MRI and SPECT study. J. Neurol. Neurosurg. Psychiatry. 73:2002;508-516.
44. Gasparini L., Gouras G.K., Wang R., Gross R.S., Beal M.F., Greengard P., Xu H. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J. Neurosci. 21:2001;2561-2570.
45. Gasparini L., Netzer W.J., Greengard P., Xu H. Does insulin dysfunction play a role in Alzheimer's disease? Trends Pharmacol. Sci. 23:2002;288-293.
46. Gjedde A., Crone C. Blood-brain glucose transfer: repression in chronic hyperglycemia. Science. 214:1981;456-457.
47. Gould E., Beylin A., Tanapat P., Reeves A., Shors T.J. Learning enhances adult neurogenesis in the hippocampal formation. Nat. Neurosci. 2:1999;260-265.
48. Gould E., Tanapat P., Hastings N.B., Shors T.J. Neurogenesis in adulthood: a possible role in learning. Trends Cogn. Sci. 3:1999;186-192.
49. Gradman T.J., Laws A., Thompson L.W., Reaven G.M. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus. J. Am. Geriatr. Soc. 41:1993;1305-1312.
50. Gregg E.W., Yaffe K., Cauley J.A., Rolka D.B., Blackwell T.L., Narayan K.M., Cummings S.R. Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch. Intern. Med. 160:2000;174-180.
51. Hall J.L., Gonder-Frederick L.A., Chewning W.W., Silveira J., Gold P.E. Glucose enhancement of performance on memory tests in young and aged humans. Neuropsychologia. 27:1989;1129-1138.
52. Havrankova J., Roth J., Brownstein M. Insulin receptors are widely distributed in the central nervous system of the rat. Nature. 272:1978;827-829.
53. Havrankova J., Schmechel D., Roth J., Brownstein M. Identification of insulin in rat brain. Proc. Natl. Acad. Sci. U. S. A. 75:1978;5737-5741.
54. Hoyer S., Lannert H. Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann. N.Y. Acad. Sci. 893:1999;301-303.
55. Hoyer S., Lee S.K., Loffler T., Schliebs R. Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease? Ann. N.Y. Acad. Sci. 920:2000;256-258.
56. Hughes R.N. Sex-related glucose effects on responsiveness to brightness change in middle-aged rats. Pharmacol. Biochem. Behav. 73:2002;485-490.
57. Hughes R.N. Effects of glucose on responsiveness to change in young adult and middle-aged rats. Physiol. Behav. 78:2003;529-534.
58. Ibberson M., Uldry M., Thorens B. GLUTX1, a novel mammalian glucose transporter expressed in the central nervous system and insulin-sensitive tissues. J. Biol. Chem. 275:2000;4607-4612.
59. Jackson-Guilford J., Leander J.D., Nisenbaum L.K. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Neurosci. Lett. 293:2000;91-94.
60. Jin K., Xie L., Childs J., Sun Y., Mao X.O., Logvinova A., Greenberg D.A. Cerebral neurogenesis is induced by intranasal administration of growth factors. Ann. Neurol. 53:2003;405-409.
61. Kalmijn S., Feskens E.J., Launer L.J., Stijnen T., Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia. 38:1995;1096-1102.
62. Kern W., Born J., Schreiber H., Fehm H.L. Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes. 48:1999;557-563.
63. Kern W., Peters A., Fruehwald-Schultes B., Deininger E., Born J., Fehm H.L. Improving influence of insulin on cognitive functions in humans. Neuroendocrinology. 74:2001;270-280.
64. Kim H.B., Jang M.H., Shin M.C., Lim B.V., Kim Y.P., Kim K.J., Kim E.H., Kim C.J. Treadmill exercise increases cell proliferation in dentate gyrus of rats with streptozotocin-induced diabetes. J. Diabetes Complications. 17:2003;29-33.
65. Kohler S., Black S.E., Sinden M., Szekely C., Kidron D., Parker J.L., Foster J.K., Moscovitch M., Winocour G., Szalai J.P., Bronskill M.J., Wincour G. Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer's disease. Neuropsychologia. 36:1998;901-914.
66. Kopf S.R., Baratti C.M. The impairment of retention induced by insulin in mice may be mediated by a reduction in central cholinergic activity. Neurobiol. Learn. Mem. 63:1995;220-228.
67. Kopf S.R., Baratti C.M. Effects of posttraining administration of glucose on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiol. Learn. Mem. 65:1996;253-260.
68. Kopf S.R., Baratti C.M. Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiol. Learn. Mem. 71:1999;50-61.
69. Kopf S.R., Boccia M.M., Baratti C.M. AF-DX 116, a presynaptic muscarinic receptor antagonist, potentiates the effects of glucose and reverses the effects of insulin on memory. Neurobiol. Learn. Mem. 70:1998;305-313.
70. Kurochkin I.V., Goto S. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:1994;33-37.
71. Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Vanhanen M., Hanninen T., Kervinen K., Kesaniemi Y.A., Riekkinen P.J., Laakso M. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. Br. Med. J. 315:1997;1045-1049.
72. Lee M.K., Graham S.N., Gold P.E. Memory enhancement with posttraining intraventricular glucose injections in rats. Behav. Neurosci. 102:1988;591-595.
73. Leibson C.L., Rocca W.A., Hanson V.A., Cha R., Kokmen E., O'Brien P.C., Palumbo P.J. The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. N.Y. Acad. Sci. 826:1997;422-427.
74. Lowe L.P., Tranel D., Wallace R.B., Welty T.K. Type II diabetes and cognitive function. A population-based study of Native Americans. Diabetes Care. 17:1994;891-896.
75. Magistretti P.J. Brain energy metabolism. Squire L.R., Bloom F.E., McConnell S.K., Roberts J.L., Spitzer N.C., Zigmond M.J. Fundamental Neuroscience. 2003;339-360 Academic Press, San Diego, CA.
76. Manning C.A., Ragozzino M.E., Gold P.E. Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's type. Neurobiol. Aging. 14:1993;523-528.
77. Manning C.A., Honn V.J., Stone W.S., Jane J.S., Gold P.E. Glucose effects on cognition in adults with Down's syndrome. Neuropsychology. 12:1998;479-484.
78. Manning C.A., Stone W.S., Korol D.L., Gold P.E. Glucose enhancement of 24-h memory retrieval in healthy elderly humans. Behav. Brain Res. 93:1998;71-76.
79. Manns J.R., Hopkins R.O., Reed J.M., Kitchener E.G., Squire L.R. Recognition memory and the human hippocampus. Neuron. 37:2003;171-180.
80. Manns J.R., Hopkins R.O., Squire L.R. Semantic memory and the human hippocampus. Neuron. 38:2003;127-133.
81. McDermott J.R., Gibson A.M. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 22:1997;49-56.
82. McNay E.C., Fries T.M., Gold P.E. Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2881-2885.
83. McNay E.C., McCarty R.C., Gold P.E. Fluctuations in brain glucose concentration during behavioral testing: dissociations between brain areas and between brain and blood. Neurobiol. Learn. Mem. 75:2001;325-337.
84. Mehlhorn G., Loffler T., Apelt J., Rossner S., Urabe T., Hattori N., Nagamatsu S., Bigl V., Schliebs R. Glucose metabolism in cholinoceptive cortical rat brain regions after basal forebrain cholinergic lesion. Int. J. Dev. Neurosci. 16:1998;675-690.
85. Meneilly G.S., Cheung E., Tessier D., Yakura C., Tuokko H. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J. Gerontol. 48:1993;M117-M121.
86. Messier C. Object recognition in mice: improvement of memory by glucose. Neurobiol. Learn. Mem. 67:1997;172-175.
87. Messier C. The absence of effect of glucose on memory is associated with low susceptibility to the amnestic effects of scopolamine in a strain of mice. Behav. Brain Res. 96:1998;47-57.
88. Messier C. Diabetes, Alzheimer's disease and apolipoprotein genotype. Exp. Gerontol. 38:2003;941-946.
89. Messier C., Pierre J., Desrochers A., Gravel M. Dose-dependent action of glucose on memory processes in women: effect on serial position and recall priority. Brain Res. Cogn. Brain Res. 7:1998;221-233.
90. Messier C., Desrochers A., Gagnon M. Effect of glucose, glucose regulation, and word imagery value on human memory. Behav. Neurosci. 113:1999;431-438.
91. Mitrakou A., Ryan C., Veneman T., Mokan M., Jenssen T., Kiss I., Durrant J., Cryer P., Gerich J. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am. J. Physiol. 260:1991;E67-E74.
92. Mufson E.J., Kordower J.H. Cholinergic basal forebrain systems in the primate central nervous system: anatomy, connectivity, neurochemistry, aging, dementia, and experimental therapeutics. Hof P.R., Mobbs C.V. Functional Neurobiology of Aging. 2001;243-281 Academic Press, San Diego, CA.
93. Naor M., Steingruber H.J., Westhoff K., Schottenfeld-Naor Y., Gries A.F. Cognitive function in elderly non-insulin-dependent diabetic patients before and after inpatient treatment for metabolic control. J. Diabetes Complications. 11:1997;40-46.
94. Okaichi Y., Okaichi H. Effects of glucose on scopolamine-induced learning deficits in rats performing the Morris water maze task. Neurobiol. Learn. Mem. 74:2000;65-79.
95. Ott A., Stolk R.P., van Harskamp F., Pols H.A., Hofman A., Breteler M.M. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology. 53:1999;1937-1942.
96. Palovcik R.A., Phillips M.I., Kappy M.S., Raizada M.K. Insulin inhibits pyramidal neurons in hippocampal slices. Brain Res. 309:1984;187-191.
97. Park C.R., Seeley R.J., Craft S., Woods S.C. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol. Behav. 68:2000;509-514.
98. Parsons M.W., Gold P.E. Glucose enhancement of memory in elderly humans: an inverted-U dose-response curve. Neurobiol. Aging. 13:1992;401-404.
99. Peila R., Rodriguez B.L., Launer L.J. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study. Diabetes. 51:2002;1256-1262.
100. Pellerin L., Magistretti P.J. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc. Natl. Acad. Sci. U. S. A. 91:1994;10625-10629.
101. Perlmuter L.C., Hakami M.K., Hodgson-Harrington C., Ginsberg J., Katz J., Singer D.E., Nathan D.M. Decreased cognitive function in aging non-insulin-dependent diabetic patients. Am. J. Med. 77:1984;1043-1048.
102. Petersen R.C., Jack C.R. Jr., Xu Y.C., Waring S.C., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Boeve B.F., Kokmen E. Memory and MRI-based hippocampal volumes in aging and AD. Neurology. 54:2000;581-587.
103. Qiu W.Q., Walsh D.M., Ye Z., Vekrellis K., Zhang J., Podlisny M.B., Rosner M.R., Safavi A., Hersh L.B., Selkoe D.J. Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J. Biol. Chem. 273:1998;32730-32738.
104. Ragozzino M.E., Arankowsky-Sandoval G., Gold P.E. Glucose attenuates the effect of combined muscarinic-nicotinic receptor blockade on spontaneous alternation. Eur. J. Pharmacol. 256:1994;31-36.
105. Ragozzino M.E., Unick K.E., Gold P.E. Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose. Proc. Natl. Acad. Sci. U. S. A. 93:1996;4693-4698.
106. Ramlo-Halsted B.A., Edelman S.V. The natural history of type 2 diabetes. Implications for clinical practice. Prim. Care. 26:1999;771-789.
107. Razay G., Wilcock G.K. Hyperinsulinaemia and Alzheimer's disease. Age Ageing. 23:1994;396-399.
108. Reagan L.P., Gorovits N., Hoskin E.K., Alves S.E., Katz E.B., Grillo C.A., Piroli G.G., McEwen B.S., Charron M.J. Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc. Natl. Acad. Sci. U. S. A. 98:2001;2820-2825.
109. Reaven G.M., Thompson L.W., Nahum D., Haskins E. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care. 13:1990;16-21.
110. Ryan C.M., Geckle M. Why is learning and memory dysfunction in Type 2 diabetes limited to older adults? Diabetes Metab. Res. Rev. 16:2000;308-315.
111. Santucci A.C., Schroeder H., Riccio D.C. Homeostatic disruption and memory: effect of insulin administration in rats. Behav. Neural Biol. 53:1990;321-333.
112. Schulingkamp R.J., Pagano T.C., Hung D., Raffa R.B. Insulin receptors and insulin action in the brain: review and clinical implications. Neurosci. Biobehav. Rev. 24:2000;855-872.
113. Schwarzberg H., Bernstein H.G., Reiser M., Gunther O. Intracerebroventricular administration of insulin attenuates retrieval of a passive avoidance response in rats. Neuropeptides. 13:1989;79-81.
114. Skeberdis V.A., Lan J., Zheng X., Zukin R.S., Bennett M.V. Insulin promotes rapid delivery of N-methyl-D-aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. U. S. A. 98:2001;3561-3566.
115. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth P., Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 97:2000;6037-6042.
116. Sommerfield A.J., Deary I.J., McAulay V., Frier B.M. Moderate hypoglycemia impairs multiple memory functions in healthy adults. Neuropsychology. 17:2003;125-132.
117. Squire L.R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99:1992;195-231.
118. Squire L.R., Zola S.M. Structure and function of declarative and nondeclarative memory systems. Proc. Natl. Acad. Sci. U. S. A. 93:1996;13515-13522.
119. Stone W.S., Cottrill K.L., Walker D.L., Gold P.E. Blood glucose and brain function: interactions with CNS cholinergic systems. Behav. Neural Biol. 50:1988;325-334.
120. Stone W.S., Croul C.E., Gold P.E. Attenuation of scopolamine-induced amnesia in mice. Psychopharmacology (Berl.). 96:1988;417-420.
121. Stone W.S., Rudd R.J., Gold P.E. Glucose attenuation of atropine-induced deficits in paradoxical sleep and memory. Brain Res. 694:1995;133-138.
122. Strachan M.W., Deary I.J., Ewing F.M., Frier B.M. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care. 20:1997;438-445.
123. Sunram-Lea S.I., Foster J.K., Durlach P., Perez C. The effect of retrograde and anterograde glucose administration on memory performance in healthy young adults. Behav. Brain Res. 134:2002;505-516.
124. Thorne R.G., Frey W.H. II Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin. Pharmacokinet. 40:2001;907-946.
125. Tong L., Thornton P.L., Balazs R., Cotman C.W. Beta-amyloid-(1-42) impairs activity-dependent cAMP-response element-binding protein signaling in neurons at concentrations in which cell survival is not compromised. J. Biol. Chem. 276:2001;17301-17306.
126. Unger J.W., Livingston J.N., Moss A.M. Insulin receptors in the central nervous system: localization, signalling mechanisms and functional aspects. Prog. Neurobiol. 36:1991;343-362.
127. Vanhanen M., Koivisto K., Kuusisto J., Mykkanen L., Helkala E.L., Hanninen T., Riekkinen P. Sr., Soininen H., Laakso M. Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care. 21:1998;398-402.
128. Vanhanen M., Kuusisto J., Koivisto K., Mykkanen L., Helkala E.L., Hanninen T., Riekkinen P. Sr., Soininen H., Laakso M. Type-2 diabetes and cognitive function in a non-demented population. Acta Neurol. Scand. 100:1999;97-101.
129. Vannucci S.J., Koehler-Stec E.M., Li K., Reynolds T.H., Clark R., Simpson I.A. GLUT4 glucose transporter expression in rodent brain: effect of diabetes. Brain Res. 797:1998;1-11.
130. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924:2002;133-140.
131. Watson G.S., Peskind E.R., Asthana S., Purganon K., Wait C., Chapman D., Schwartz M.W., Plymate S., Craft S. Insulin increases CSF Ab42 levels in normal older adults. Neurology. 60:2003;1899-1903.
132. Westerman M.A., Cooper-Blacketer D., Mariash A., Kotilinek L., Kawarabayashi T., Younkin L.H., Carlson G.A., Younkin S.G., Ashe K.H. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 22:2002;1858-1867.
133. Widom B., Simonson D.C. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann. Intern. Med. 112:1990;904-912.
134. Winocur G., Gagnon S. Glucose treatment attenuates spatial learning and memory deficits of aged rats on tests of hippocampal function. Neurobiol. Aging. 19:1998;233-241.
135. Zhao W., Chen H., Xu H., Moore E., Meiri N., Quon M.J., Alkon D.L. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J. Biol. Chem. 274:1999;34893-34902.